448 related articles for article (PubMed ID: 17075653)
1. Topical treatments for melasma and postinflammatory hyperpigmentation.
Lynde CB; Kraft JN; Lynde CW
Skin Therapy Lett; 2006 Nov; 11(9):1-6. PubMed ID: 17075653
[TBL] [Abstract][Full Text] [Related]
2. Skin lightening preparations and the hydroquinone controversy.
Draelos ZD
Dermatol Ther; 2007; 20(5):308-13. PubMed ID: 18045355
[TBL] [Abstract][Full Text] [Related]
3. New and experimental treatments of cloasma and other hypermelanoses.
Picardo M; Carrera M
Dermatol Clin; 2007 Jul; 25(3):353-62, ix. PubMed ID: 17662901
[TBL] [Abstract][Full Text] [Related]
4. UK-based dermatologist online survey on the current practice and training in the management of melasma and postinflammatory hyperpigmentation.
Ma Y; Millette D; Nalluri R; Yoo J
Clin Exp Dermatol; 2020 Jun; 45(4):483-484. PubMed ID: 32061135
[No Abstract] [Full Text] [Related]
5. Treatment of hyperpigmentation.
Rossi AM; Perez MI
Facial Plast Surg Clin North Am; 2011 May; 19(2):313-24. PubMed ID: 21763992
[TBL] [Abstract][Full Text] [Related]
6. Topical agents used in the management of hyperpigmentation.
Halder RM; Richards GM
Skin Therapy Lett; 2004; 9(6):1-3. PubMed ID: 15334278
[TBL] [Abstract][Full Text] [Related]
7. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation.
Grimes PE
Cutis; 2004 Dec; 74(6):362-8. PubMed ID: 15663072
[TBL] [Abstract][Full Text] [Related]
8. Hydroquinone--what is its future?
Toombs EL
Dermatol Ther; 2007; 20(3):149-56. PubMed ID: 17803610
[No Abstract] [Full Text] [Related]
9. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Mehta RC; Garruto J; Gotz V; Sigler ML; Herndon JH
J Drugs Dermatol; 2013 Mar; 12(3):s21-6. PubMed ID: 23545929
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Herndon JH; Sigler ML; Gotz V; Garruto J; Mehta RC
J Drugs Dermatol; 2012 Dec; 11(12):1478-82. PubMed ID: 23377519
[TBL] [Abstract][Full Text] [Related]
11. Retinoids and azelaic acid to treat acne and hyperpigmentation in skin of color.
Woolery-Lloyd HC; Keri J; Doig S
J Drugs Dermatol; 2013 Apr; 12(4):434-7. PubMed ID: 23652891
[TBL] [Abstract][Full Text] [Related]
12. Hyperpigmentation: an overview of the common afflictions.
Cayce KA; McMichael AJ; Feldman SR
Dermatol Nurs; 2004 Oct; 16(5):401-6, 413-6; quiz 417. PubMed ID: 15624705
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
[TBL] [Abstract][Full Text] [Related]
15. Hyperpigmentation and melasma.
Rigopoulos D; Gregoriou S; Katsambas A
J Cosmet Dermatol; 2007 Sep; 6(3):195-202. PubMed ID: 17760699
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
Monheit GD; Dreher F
J Drugs Dermatol; 2013 Mar; 12(3):270-4. PubMed ID: 23545908
[TBL] [Abstract][Full Text] [Related]
17. A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads.
Torok H; Taylor S; Baumann L; Jones T; Wieder J; Lowe N; Jarret M; Rich P; Pariser D; Tschen E; Martin D; Menter A; Weiss J
J Drugs Dermatol; 2005; 4(5):592-7. PubMed ID: 16167418
[TBL] [Abstract][Full Text] [Related]
18. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
Kaufman BP; Alexis AF
J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
[TBL] [Abstract][Full Text] [Related]
19. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.
Nanda S; Grover C; Reddy BS
Dermatol Surg; 2004 Mar; 30(3):385-8; discussion 389. PubMed ID: 15008866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
